Cooley, Latham Steer RNA Drugmaker's Upsized $446M IPO
San Diego-based biotechnology company ADARx Pharmaceuticals began trading publicly on Friday after raising $446 million in its initial public offering steered by Cooley LLP and Latham & Watkins LLP, adding to...To view the full article, register now.
Already a subscriber? Click here to view full article